Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $45
Enovis Q2 Earnings Call Highlights
Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $39
Enovis Corporation 2026 Q2 - Results - Earnings Call Presentation
Enovis Corporation (ENOV) Q2 2026 Earnings Call Transcript
Enovis Corp (ENOV) (Q2 2026) Earnings Call Highlights: Strong Innovation Drives 5% Organic ...
BTIG Maintains Buy on Enovis, Raises Price Target to $40
Enovis (NYSE:ENOV) Posts Q2 CY2026 Sales In Line With Estimates
Enovis Announces Second Quarter 2026 Results
Enovis Q2 Adj. EPS $0.90 Beats $0.85 Estimate, Sales $582.782M Beat $582.542M Estimate
Enovis Affirms FY2026 Adj EPS Guidance of $3.52-$3.73 vs $3.65 Est; Affirms FY2026 Sales Guidance of $2.310B-$2.370B vs $2.345B Est
Is Enovis (ENOV) Signaling a Deeper Shift as Returns on Capital and Sales Decline?
Enovis (ENOV) Faces A Tougher Outlook On Sales Pressure And Undervalued Narrative
1 Unprofitable Stock to Own for Decades and 2 Facing Challenges
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
Enovis (ENOV) Stock Trades Up, Here Is Why
Enovis™ Companion Animal Health Launches CT-RevitL™, the Next-Generation Laser Therapy System for Veterinary Care
BMO Capital Initiates Coverage of Enovis (ENOV) with Outperform Recommendation
BMO Capital Initiates Coverage On Enovis with Outperform Rating, Announces Price Target of $29
Why Enovis (ENOV) Stock Is Trading Up Today
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.